Table 1.
Epidemiologic and clinical characteristics of patients pulmonary nocardiosis, according to eGFR (n = 56)
| eGFR > 45 | eGFR ≤45 | p value | |
|---|---|---|---|
| n | 42 | 14 | |
| Age (years) a | 67.4 ± 2.5 | 67.7 ± 2.9 | 0.55 |
| Gender (Male/Female) | 21/21 | 6/8 | 0.64 |
| BMI (kg/m2) a | 22.2 ± 0.7 | 22.2 ± 1.7 | 0.53 |
| Diagnosis | |||
| Clinical | 24 (57.1%) | 7 (50.0%) | 0.64 |
| Histological | 10 (23.8%) | 2 (14.3%) | 0.44 |
| Pathogenic | 10 (23.8%) | 7 (50.0%) | 0.07 |
| Disseminated cryptococcosis | 1 (2.4%) | 3 (21.4%) | 0.03 |
| Comorbidity | |||
| Pulmonary diseases | 4 (9.5%) | 1 (7.1%) | 0.78 |
| Diabetes mellitus | 12 (28.6%) | 6 (42.9%) | 0.33 |
| Connective tissue diseases | 4 (9.5%) | 2 (14.3%) | 0.63 |
| Malignancy | 12 (28.6%) | 2 (14.3%) | 0.26 |
| Immunosuppressive drug use | 14 (33.3%) | 9 (64.3%) | 0.04 |
| On hemodialysis | 0 (0.0%) | 1 (7.1%) | 0.09 |
eGFR estimated glomerular filtration rate, BMI body mass index
a Data are presented as mean ± standard deviation